Health
Creador acquires minority stake in Vietnam’s pharmacy chains FPT Long Chau Investment JSC
Creador, a Malaysia-based private equity firm in South and Southeast Asia, has announced the acquisition of up to 13 percent in FPT Long Chau Investment JSC (Long Chau), one of Vietnam’s leading pharmacy chains.
This marks the first ever fundraise by Long Chau and the second investment made in Vietnam by Creador, Creador said in a statement on last Friday.
Long Chau has grown from four stores in 2017 to over 2,000 pharmacies and over 140 vaccination centers in Vietnam today.
It is...
The human code: How physical AI is rewriting the future of care
By the time you finish reading this article, somewhere in the world, a robot will have helped a stroke survivor move an arm, reminded an elderly patient to take their medication, or encouraged a toddler to get active. Physical artificial intelligence (AI) isn’t just testing our technological capability. It is testing our values.
Across aged care, education, and hospitals, physical AI – robots that move, sense, and interact in the real world – is emerging as a powerful and...
Malaysia’s digital third-party administrator HealthMetrics launches in Indonesia
HealthMetrics, a Malaysia-based digital third-party administrator (TPA), announced the official launch of HealthMetrics Indonesia – uniting the longstanding expertise of Across Asia Assist Indonesia (AAA) with its advanced digital infrastructure to create a single, integrated digital TPA powerhouse poised to transform healthcare administration in Indonesia and Southeast Asia.
HealthMetrics said in a statement on last Friday that for over a decade, Across Asia Assist Indonesia has...
How AI is transforming healthcare accreditation processes
Healthcare accreditation is a vital benchmark for quality, safety, and compliance in medical institutions. In Southeast Asia and the broader Asia-Pacific (APAC) region, artificial intelligence (AI) is emerging as a transformative force, streamlining accreditation processes and enhancing healthcare delivery.
AI’s role in streamlining accreditation
AI technologies are revolutionizing how healthcare institutions approach accreditation by automating complex tasks and enhancing data...
Li Ka Shing Foundation, Temasek Trust jointly commit $9M to acquire systems and advance clinical trial for innovative histotripsy cancer therapy in Singapore
The Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) have committed S$12 million ($8.99 million) to bring innovative non-invasive ultrasound-based histotripsy tumor clinical trials to Singapore.
The duo said in a statement on Friday that the National Cancer Centre Singapore (NCCS) and the National University Cancer Institute, Singapore (NCIS) will each receive one Histotripsy System – the first of such to be available in Southeast Asia.
The funding from LKSF and TT will also...
Temasek renews investment in global animal health firm Ceva Animal Health
Ceva Animal Health (Ceva), the world’s fifth-largest animal health company, said the Singapore-based global investment firm Temasek has renewed its investment in the company.
Ceva announced in a statement on Monday the restructuring of its capital.
According to the statement, all investors including pure investors led by Temasek, have renewed their investment, demonstrating their confidence in the company’s ability to continue its sustained growth.
It noted the long-standing...
Temasek and GIC acquire stake in Singapore-headquartered biotech specialist CRO Novotech
Novotech, Singapore-headquartered full-service biotech specialist clinical research organization (CRO), announced that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth.
Existing investor TPG will also reinvest through its TPG Asia fund, Novotech said in a statement on last Sunday.
According to the statement, the reinvestment by TPG Asia and investment from GIC and...
HKUST partners SIIC to launch Hong Kong biotechnology fund
The Hong Kong University of Science and Technology (HKUST) and Shanghai Industrial Investment (Holdings) Co., Ltd. (SIIC) have announced the establishment of the Hong Kong Biotechnology Fund (HKBF) to foster innovation in the life sciences sector.
The duo said in a statement on last Thursday that with HKUST and SIIC committed as the anchor investors with a target fund size of HK$600 million ($77.2 million), at least half of the fund is dedicated for ventures associated with HKUST, including...
VNPT - VinaPhone tuyển Cộng tác viên bán hàng
VinaPhone là một trong ba nhà mạng hàng đầu tại Việt Nam. Nhằm mở rộng mạng lưới phát triển kinh doanh, đưa các dịch vụ chất lượng cao của VNPT tới mọi người, mọi nhà, VNPT VinaPhone kính mời Quý khách hàng, đối tác tham gia làm Cộng tác viên (CTV) bán hàng của chúng tôi.
Chúng tôi đang tìm kiếm những CTV bán...
Thailand’s HD HD boosts Series A to $7.8M to accelerate healthcare marketplace and AI in Southeast Asia
HD, a Thailand-based healthcare and surgery marketplace, has on Thursday announced the close of a Series A-1 strategic extension round with participation from the United States-based healthcare firm Merck Sharp & Dohme (MSD), bringing HD’s total Series A funding to $7.8 million.
HD said in a statement that with additional support from from MSD, HD is poised to expand its impact even further, making affordable, accessible healthcare a reality across Southeast Asia.
By 2025, the...
Life Science Incubator unveils Singapore’s largest co-working laboratory at Elementum
Life Science Incubator (LSI) has officially launched the largest co-working laboratory in Singapore at Elementum, located in JTC’s one-north business park.
This launch further strengthens Singapore’s prominence as a premier life sciences hub in Asia Pacific, LSI said in a statement on Monday.
As Singapore continues to be a preferred destination for biotech, MedTech, and pharmaceutical innovation, LSI opined that the demand for high-quality laboratory space remains high.
It said...
How data analytics and business intelligence are driving discovery and innovation in healthcare
Innovation in the healthcare industry is not a choice but a need to generate cost-effective solutions and better patient outcomes. The balance of data analytics and business intelligence with due diligence spurs potential areas of discovery, optimizes regular operations, and elevates healthcare quality. Business intelligence in healthcare involves collecting and processing extensive data from diverse sources such as digital health records, medi-claim documents, history of treatments,...
More Blogs
Sponsored
Read More
Pepper Labs collaborates with Microsoft to boost AI fluency in Malaysia
🇲🇾🤝 Pepper Labs teams up with Microsoft to expand the #AIForMYFuture initiative — aiming to...
NCT partners with OM Charge to build EV infrastructure at NSIP
Malaysia’s Managed Industrial Park (MIP) NCT Group of Companies, has partnered with OM...
AirAsia MOVE appoints travel industry veteran Manfredi Lefebvre d’Ovidio as Chairman
Malaysia-based Capital A’s online travel agent (OTA) platform AirAsia MOVE has announced...
Amazon unveils new Singapore office as AWS Asia Pacific Hub
American multinational technology company Amazon has continued to expand its presence in...
Chi tiết về 52 tỉnh, thành trong diện đề xuất sáp nhập
Trong số 52 tỉnh thành thuộc diện đề xuất sáp nhập, nếu chia theo 3 miền thì...